Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO).
about
Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedbackMicroglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.Lead discovery for human kynurenine 3-monooxygenase by high-throughput RapidFire mass spectrometry.
P2860
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@en
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@nl
type
label
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@en
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@nl
prefLabel
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@en
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@nl
P2093
P2860
P356
P1476
Development of LC/MS/MS, high- ...... ynurenine monooxygenase (KMO).
@en
P2093
Andreas Ebneth
Celia Dominguez
Dirk Winkler
Ignacio Muñoz-Sanjuan
Leticia M Toledo-Sherman
Maria Beconi
Michael Prime
P2860
P304
P356
10.1177/1087057113489731
P577
2013-05-20T00:00:00Z